IMDXSector not reported
Insight Molecular Diagnostics Inc. (IMDX) Insider Trading
In the last 90 days, 3 Insight Molecular Diagnostics Inc. (IMDX) insiders reported 3 open-market purchases totaling $17,999,998 and no sales. The most recent open-market purchase was reported on Nov 17, 2026. Source: SEC Form 4 filings.
SEC-reported filing activity is provided for research purposes and is not investment advice.
- 90-day C-suite buyers
- 0
- 90-day purchase value
- $17,999,998
- Corporate buyers
- 3
- Latest transaction
- Nov 17, 2026
Executive filings
Open-market transaction history
Purchase and sale summaries are ordered by the latest reported transaction date.
Common questions
IMDX insider trading FAQ
- Are IMDX insiders buying or selling?
- Over the last 90 days, IMDX insiders were net buyers, reporting $17,999,998 of open-market purchases and $0.00 of sales.
- When was the last IMDX insider purchase?
- The most recent open-market purchase of Insight Molecular Diagnostics Inc. stock by an insider was reported on Nov 17, 2026, one of 3 purchases in the last 90 days.
- Where does IMDX insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings that Insight Molecular Diagnostics Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.
